Hideo Saka
Overview
Explore the profile of Hideo Saka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
2554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kogure Y, Hashimoto H, Daga H, Fukuda Y, Bessho A, Yamada T, et al.
JTO Clin Res Rep
. 2025 Feb;
6(3):100784.
PMID: 40007549
Introduction: Pembrolizumab with pemetrexed and cisplatin/carboplatin is an approved first-line treatment for metastatic nonsquamous NSCLC. Nevertheless, its efficacy and safety in patients aged 75 years and above remain unclear. We...
2.
Oki M, Saka H, Seki Y, Kogure Y, Niwa H, Yamada A, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39624385
Introduction: Both combined endobronchial ultrasonography (EBUS) and transoesophageal bronchoscopic ultrasonography (EUS-B) and EBUS alone have been recommended for preoperative mediastinal staging of nonsmall cell lung cancer (NSCLC). However, no randomised...
3.
Chaddha U, Agrawal A, Kurman J, Ortiz-Comino R, Dutau H, Freitag L, et al.
Respirology
. 2024 May;
29(7):563-573.
PMID: 38812262
Malignant Central Airway Obstruction (MCAO) encompasses significant and symptomatic narrowing of the central airways that can occur due to primary lung cancer or metastatic disease. Therapeutic bronchoscopy is associated with...
4.
Torii A, Oki M, Iida H, Yamada A, Kogure Y, Kitagawa C, et al.
Pulm Pharmacol Ther
. 2024 Mar;
85:102297.
PMID: 38467341
Background And Objective: Other iatrogenic immunodeficiency-associated lymphoproliferative disorders (OIIA-LPD) are rare but well-known diseases that manifest during or after methotrexate (MTX) administration. Limited information is available on the clinical characteristics...
5.
Soumagne T, Dutau H, Eapen G, Guibert N, Hergott C, Maldonado F, et al.
Respiration
. 2024 Feb;
103(3):146-154.
PMID: 38402862
Introduction: The investigation of peripheral pulmonary lesions (PPLs) can be challenging. Several bronchoscopic modalities have been developed to reach and biopsy PPL but the level of adoption of these techniques...
6.
Nogami N, Tokito T, Zenke Y, Satouchi M, Seto T, Saka H, et al.
Invest New Drugs
. 2024 Feb;
42(1):136-144.
PMID: 38300341
Background: Part E of the KEYNOTE-011 (NCT01840579) study assessed the safety and antitumor activity of pembrolizumab plus platinum-etoposide chemotherapy in Japanese patients with previously untreated extensive-stage small-cell lung cancer (ES-SCLC)....
7.
Saka H, Oki M, Yamauchi Y, Kitagawa C, Kada A, Saito A, et al.
Respir Investig
. 2024 Jan;
62(2):277-283.
PMID: 38266551
Background: Secondary pneumothorax, which occurs most commonly in the elderly, is caused by underlying diseases. Cardiac dysfunction and other organ inefficiencies may render surgical repair impossible. Such non-operative and poor-risk...
8.
Okamoto S, Somiya N, Hotta R, Saka H, Oki M, Tomita A
Kurume Med J
. 2024 Jan;
69(3.4):135-142.
PMID: 38233186
Airway stenting involves a stent being inserted into a stenotic site in the airway. In patients with airway stenosis, the airway is the surgical field; therefore, anesthetic management is challenging,...
9.
Kenmotsu H, Yamamoto N, Misumi T, Yoh K, Saito H, Sugawara S, et al.
J Clin Oncol
. 2023 Sep;
41(34):5242-5246.
PMID: 37656928
JCO The JIPANG study is an open-label phase III trial evaluating the efficacy of pemetrexed plus cisplatin (PemP) versus vinorelbine plus cisplatin (NP) as adjuvant chemotherapy in patients with stage...
10.
Kogure Y, Kada A, Hashimoto H, Atagi S, Takiguchi Y, Saka H, et al.
JTO Clin Res Rep
. 2023 Jun;
4(6):100514.
PMID: 37304652
Introduction: In the CAPITAL study, a randomized phase 3 study, wherein carboplatin plus nab-paclitaxel treatment was compared with docetaxel treatment for older patients with squamous-cell lung cancer, the former became...